4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001144204-18-033608
Options or other derivatives
- Chief Science Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| PICKER DONALD H Chief Science Officer | 2018-06-06 | Grant or award · Stock option (right to buy) | +75,000 | 135,000 | D | ||
Loading xslF345X03/tv496092_4.xml…